3-Methyl-2-cyclohexen-1-one and Its Associated End-use Products, Proposed Re evaluation Decision (PRVD2024-05)
Health Canada is consulting Canadians on the proposal to continue registration of products containing 3-methyl-2-cyclohexen-1-one (also referred to as methylcyclohexenone)